Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001140361-26-035319

Options or other derivatives

  • Chief Executive Officer acquired 267,160 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kohli Prashant · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +267,160 267,160 D
Loading xslF345X06/form4.xml…